Clinical profile of patients and sensitivity of troponin I in patients with and without acute coronary syndrome: An observational study
The National Medical Journal of India · 2024
DOI: 10.25259/nmji_801_2021 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The National Medical Journal of India, 2024. Verfasst von Shruthi M Kulkarni und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, St John's Medical College Hospital, Koramangala, Bengaluru 560034, Karnataka, India. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Troponin I, Sensitivity and Specificity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Background
Various clinical conditions can cause troponin elevation in the absence of myocardial ischaemia. Elevated troponin represents the likely occurrence of myocardial necrosis and does not itself provide any indication of the aetiology. Identifying the cause for troponin elevation and its sensitivity and specificity in predicting acute coronary syndrome (ACS) and cardiac mortality is an important step in determining the optimal management for these patients.
Methods
We retrospectively collected data of inpatients who had troponin I (TnI) testing as part of their clinical assessment, either in the emergency department, medical wards, coronary care unit (CCU) or intensive care unit (ICU) with their final diagnosis. TnI was used as the index test of sensitivity to diagnose ACS and either echocardiography or coronary angiogram in those available as the reference gold standard. They were classified into two groups of normal and elevated TnI, and further divided into those with ACS and no ACS. Data on clinical parameters and aetiology of elevated TnI in patients without ACS were analysed.
Results
Of the 254 patients studied, 114 patients (45%) had normal TnI and 140 (55%) had elevated TnI. Seventy-eight patients had ACS, 66 (84.6%) of whom had elevated TnI and 12 (15.38%) had normal TnI. Seventy-four (52.85%) of 140 patients with elevated TnI had alternate causes of TnI elevation; the most common being sepsis, acute kidney injury (AKI) and heart failure without ACS. All-cause mortality was significantly higher in patients with elevated TnI with or without ACS. There was no cardiac mortality among patients with ACS with normal TnI. Sensitivity and specificity of TnI for predicting ACS was 84.6% (95% CI 74.7%–91.8%) and 58% (95% CI 50.3%–65.3%), respectively.
Conclusion
A variety of conditions apart from myocardial infarction can lead to elevated TnI. Hence, caution should be exercised while diagnosing a patient with ACS based on TnI value in the absence of other supporting evidence given its low specificity. Elevated TnI portends a worse prognosis regardless of the aetiology and has a role in predicting all-cause and cardiac mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Medicine, St John's Medical College Hospital, Koramangala, Bengaluru 560034, Karnataka, India.
Zitieren
APA
Kulkarni, S. M., Roongta, R., & Sankar, S. (2024). Clinical profile of patients and sensitivity of troponin I in patients with and without acute coronary syndrome: An observational study. The National Medical Journal of India. https://doi.org/10.25259/nmji_801_2021
Vancouver
Kulkarni SM, Roongta R, Sankar S. Clinical profile of patients and sensitivity of troponin I in patients with and without acute coronary syndrome: An observational study. The National Medical Journal of India. 2024. doi:10.25259/nmji_801_2021
BibTeX
@article{Kulkarni2024,
author = {Kulkarni, Shruthi M and Roongta, Rashmi and Sankar, Seena},
title = {Clinical profile of patients and sensitivity of troponin I in patients with and without acute coronary syndrome: An observational study},
journal = {The National Medical Journal of India},
year = {2024},
doi = {10.25259/nmji_801_2021}
}
EUVIMED